These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 8010139)
21. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers. Lues I; Beier N; Jonas R; Klockow M; Haeusler G J Cardiovasc Pharmacol; 1993 Jun; 21(6):883-92. PubMed ID: 7687712 [TBL] [Abstract][Full Text] [Related]
22. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart. Hino M; Sugawara H; Yoshimura A; Ogura A; Yoshioka K; Sakato M; Endoh M Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action. Hosokawa T; Mori T; Fujiki H; Kinoshita S; Takemoto K; Imaizumi T; Noda T; Ohura M; Tominaga M; Yabuuchi Y Heart Vessels; 1992; 7(2):66-75. PubMed ID: 1328145 [TBL] [Abstract][Full Text] [Related]
24. Effects of the new imidazopyridine CL 86-02-01 on isolated papillary muscle of guinea-pig hearts. Studenik C; Lemmens-Gruber R; Heistracher P Arzneimittelforschung; 1998 Jun; 48(6):637-40. PubMed ID: 9689419 [TBL] [Abstract][Full Text] [Related]
25. Actions of the novel vasodilator, flosequinan, in isolated ventricular cardiomyocytes. Kelso EJ; McDermott BJ; Silke B J Cardiovasc Pharmacol; 1995 Mar; 25(3):376-86. PubMed ID: 7769801 [TBL] [Abstract][Full Text] [Related]
26. TMB-8 as a pharmacologic tool in guinea pig myocardial tissues. I. Effects of TMB-8 on force of contraction and on action potential parameters in atrial and papillary muscles. Himmel HM; Ravens U J Pharmacol Exp Ther; 1990 Oct; 255(1):293-9. PubMed ID: 1698970 [TBL] [Abstract][Full Text] [Related]
27. Electrophysiological effects of OPC-88117, a new antiarrhythmic agent on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts. Toyama J; Kodama I; Honjo H; Kamiya K Br J Pharmacol; 1989 Sep; 98(1):177-85. PubMed ID: 2553186 [TBL] [Abstract][Full Text] [Related]
28. Analysis of the inotropic mechanism of enoximone in guinea pig ventricular muscle. Jonas SE; Mörner N; Christley HM; Wohlfart B J Cardiovasc Pharmacol; 1990 Sep; 16(3):423-9. PubMed ID: 1700213 [TBL] [Abstract][Full Text] [Related]
29. Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors. Wynne DG; Poole-Wilson PA; Harding SE Br J Pharmacol; 1993 Aug; 109(4):1071-8. PubMed ID: 7691363 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of OPC-8490 in human ventricular myocardium. Focaccio A; Peeters G; Movsesian M; Roden R; Eki Y; Krall J; Bristow MR Circulation; 1996 Feb; 93(4):817-25. PubMed ID: 8641012 [TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation. Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940 [TBL] [Abstract][Full Text] [Related]
32. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. Underwood DC; Kotzer CJ; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW; Torphy TJ J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322 [TBL] [Abstract][Full Text] [Related]
33. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations. Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217 [TBL] [Abstract][Full Text] [Related]
34. Effect of 1-acyl-5,6-dialkoxy-2-alkylthiobenzo[d] imidazoles on the action potential duration and isometric contraction in guinea pig atrium activated by carbachol and in guinea pig heart papillary muscles. Garaliene V; Labanauskas L; Brukstus A Arzneimittelforschung; 2006; 56(4):282-7. PubMed ID: 16724514 [TBL] [Abstract][Full Text] [Related]
35. Membrane current changes responsible for the positive inotropic effect of OPC-8212, a new positive inotropic agent, in single ventricular cells of the guinea pig heart. Iijima T; Taira N J Pharmacol Exp Ther; 1987 Feb; 240(2):657-62. PubMed ID: 2433433 [TBL] [Abstract][Full Text] [Related]
36. The action of 2,3-butane-dionemonoxime on the inotropic state in guinea-pig myocardium. Mörner SE; Wohlfart B Acta Physiol Scand; 1991 Jun; 142(2):211-9. PubMed ID: 1877370 [TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium. Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013 [TBL] [Abstract][Full Text] [Related]
38. Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts. Berger C; Meyer W; Scholz H; Starbatty J Arzneimittelforschung; 1985; 35(11):1668-73. PubMed ID: 2418846 [TBL] [Abstract][Full Text] [Related]
39. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor. Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731 [TBL] [Abstract][Full Text] [Related]